These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Hormone therapy and the risk of cancer in the climacteric]. Kuhl H; Taubert HD Gynakologe; 1986 Dec; 19(4):259-65. PubMed ID: 3817599 [No Abstract] [Full Text] [Related]
7. [Oestrogens during the menopause and the risk of endometrial carcinoma (author's transl)]. Lachnit-Fixson U Wien Klin Wochenschr; 1979 Feb; 91(4):111-8. PubMed ID: 218369 [TBL] [Abstract][Full Text] [Related]
8. Editorial: Oestrogens as a cause of endometrial carcinoma. Br Med J; 1976 Apr; 1(6013):791-2. PubMed ID: 1260334 [TBL] [Abstract][Full Text] [Related]
9. Estrogens and endometrial cancer. Schlaff WB; Rosenshein NB Md Med J; 1985 Jan; 34(1):57-62. PubMed ID: 3849646 [No Abstract] [Full Text] [Related]
10. Estrogens: do the risks outweight the benefits? Rust JA; Langley II; Hill EC; Lamb EJ Am J Obstet Gynecol; 1977 Jun; 128(4):431-9. PubMed ID: 194481 [No Abstract] [Full Text] [Related]
11. Benefits and risks of estrogen replacement therapy in the menopause. Gambrell RD; Hyatt AL Del Med J; 1984 Apr; 56(4):209-18. PubMed ID: 6714483 [No Abstract] [Full Text] [Related]
12. [Estrogens treatment in the climacteric]. Lebech PE Nord Med; 1977 May; 92(5):146-7. PubMed ID: 866103 [No Abstract] [Full Text] [Related]
13. [Estrogen metabolism and hormone substitution in the climacteric]. Göretzlehner G; Kyank H Zentralbl Gynakol; 1985; 107(16):977-88. PubMed ID: 2996259 [TBL] [Abstract][Full Text] [Related]
15. [Cost-benefit-risk analysis of estrogen treatment in the climacteric]. Lauritzen C Gynakologe; 1986 Dec; 19(4):266-75. PubMed ID: 3102324 [No Abstract] [Full Text] [Related]
16. Letter: Oestrogens as a cause of endometrial carcinoma. Cooke ID Br Med J; 1976 May; 1(6019):1209-10. PubMed ID: 1268630 [TBL] [Abstract][Full Text] [Related]